1. Home
  2. NA vs HOWL Comparison

NA vs HOWL Comparison

Compare NA & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NA

Nano Labs Ltd

N/A

Current Price

$2.19

Market Cap

51.9M

Sector

Technology

ML Signal

N/A

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

N/A

Current Price

$0.99

Market Cap

46.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NA
HOWL
Founded
2019
2017
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
46.7M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NA
HOWL
Price
$2.19
$0.99
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.6K
★ 601.6K
Earning Date
08-28-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.40
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.27
52 Week High
$5.97
$1.83

Technical Indicators

Market Signals
Indicator
NA
HOWL
Relative Strength Index (RSI) 46.10 62.45
Support Level $1.64 $0.92
Resistance Level $2.44 $0.99
Average True Range (ATR) 0.12 0.04
MACD -0.03 -0.01
Stochastic Oscillator 8.33 91.22

Price Performance

Historical Comparison
NA
HOWL

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: